November 19, 2025 FDA Qualifies C-Path Biomarker GLDH to Detect Liver Injury in Clinical Trials C-Path today announced that the U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research, through its..
November 18, 2025 C-Path’s International Neonatal Consortium Launches Groundbreaking Neonatal Lab Values GUI Tool to Standardize Reference Ranges in Neonatal Trials TUCSON, Ariz., November 18, 2025 — Critical Path Institute’s® (C-Path) International Neonatal Consortium (INC) today...
C-Path’s Critical Path for Parkinson’s Names Fatta B. Nahab, MD, as Industry Co-Director TUCSON, Ariz., November 13, 2025 — Critical Path Institute® (C-Path) today announced the appointment of Fatta B. Nahab,...
October 16, 2025 C-Path’s Disease Modeling Coalition Begins Global Pediatric IBD Work from European Hub Critical Path Institute® (C-Path) today announced the official launch of the Critical Path Disease...
October 14, 2025 Critical Path Institute to be Honored with Reagan-Udall Foundation Innovation Award Award honors regulatory science advances with measurable public health impact; ceremony December 9, 2025, Willard...
September 30, 2025 C-Path Names Colin Hill to Board of Directors C-Path today announced the election of Colin Hill to its Board of Directors. Hill brings deep experience...
September 11, 2025 C-Path Concludes 2025 Global Impact Conference with Progress Across Rare Diseases, Neurology and Pediatrics Global regulators, industry leaders, scientists, and patient advocates set near-term commitments on early interception...
September 8, 2025 C-Path Welcomes Rare Disease Advocacy Leader Ronald J. Bartek to Board of Directors C-Path today announced the election of Ronald J. Bartek to its Board of Directors...
September 4, 2025 C-Path’s Translational Therapeutics Accelerator Marks Record Year with Seven BRIDGe Awards Advancing Potential Therapies Across Cancer, Infectious Disease, Neurology and Immunology Program launched in 2022 has grown into a global pipeline partner for academic teams, awarding approximately $2.48 million...
August 21, 2025 HDYO Joins C-Path’s Huntington’s Disease Consortium to Amplify Youth Voices in Drug Development TUCSON, Ariz., August 21, 2025 — Critical Path Institute’s® (C-Path) Huntington’s Disease Regulatory Science Consortium...